This inventor holds 1 USPTO granted patent. Top assignees: Galderma Holding Sa, Ipsen Biopharm Limited. Active years: 2026.
Company Filing History:
1 out of 65 
1 out of 46 Years Active: 2026
Title: Charlotta Gauffin: Innovator in Aesthetic Treatments
Introduction
Charlotta Gauffin is a notable inventor based in Vänge, Sweden. She has made significant contributions to the field of aesthetic treatments, particularly in the use of botulinum neurotoxin for cosmetic purposes. Her innovative approach has led to advancements in the treatment of facial lines, enhancing the quality of life for many individuals.
Latest Patents
Charlotta Gauffin holds 1 patent for her work titled "Treatment of moderate to very severe glabellar lines and lateral canthal lines." This patent discloses methods for treating moderate to severe and very severe glabellar lines and lateral canthal lines using liquid botulinum neurotoxin compositions. Additionally, it includes the formulation of liquid compositions of botulinum neurotoxin, showcasing her expertise in this area.
Career Highlights
Throughout her career, Charlotta has worked with prominent companies in the pharmaceutical and aesthetic industries. Notably, she has been associated with Ipsen Biopharm Limited and Galderma Holding SA. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking treatments in aesthetic medicine.
Collaborations
Charlotta has collaborated with esteemed professionals in her field, including Andrew Pickett and Birgitta Almegård. These partnerships have fostered innovation and have been instrumental in the development of her patented treatments.
Conclusion
Charlotta Gauffin's contributions to the field of aesthetic treatments through her innovative patent demonstrate her commitment to enhancing cosmetic procedures. Her work continues to influence the industry and improve patient outcomes.